Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
PHILLIPS, Kelly-Anne, MILNE, Roger L, BUYS, Saundra S, ANDRIEU, Nadine, NOGUES, Catherine, STOPPA-LYONNET, Dominique, BONADONA, Valérie, PUJOL, Pascal, MCLACHLAN, Sue Anne, JOHN, Esther M, HOONING, Maartje J, SEYNAEVE, Caroline, ROOKUS, Matti A, TOLLENAAR, Rob A. E. M, GOLDGAR, David E, TERRY, Mary Beth, CALDES, Trinidad, WEIDEMAN, Prue C, ANDRULIS, Irene L, SINGER, Christian F, BIRCH, Kate, SIMARD, Jacques, SOUTHEY, Melissa C, DALY, Mary B, OLSSON, Håkan L, JAKUBOWSKA, Anna, OLAH, Edith, GERDES, Anne-Marie, FORETOVA, Lenka, HOPPER, John L, ANTONIOU, Antonis C, PEOCK, Susan, FROST, Debra, EASTON, Douglas F, ELLIS, Steve, FRIEDLANDER, Michael L
Published in Journal of clinical oncology (01.09.2013)
Published in Journal of clinical oncology (01.09.2013)
Get full text
Journal Article
Abstract 5582: H1-antihistamines desloratadine and loratadine show potential for cancer therapy
Fritz, Ildiko, Wagner, Philippe, Olsson, Hakan L.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
E28. Breast tolerance, tibolone compared to other hormonal treatments
Published in European journal of cancer supplements
(01.12.2004)
Get full text
Journal Article